ID

13579

Beschreibung

Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00151242

Link

https://clinicaltrials.gov/show/NCT00151242

Stichworte

  1. 17.02.16 17.02.16 -
Rechteinhaber

CC BY-NC 3.0

Hochgeladen am

17. Februar 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Acute Myeloid Leukemia DRKS00003818 NCT00151242

Eligibility Acute Myeloid Leukemia NCT00151242

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
newly diagnosed aml defined according to the world health organization (who)-classification (excluding acute promyelocytic leukemia [apl])
Beschreibung

newly diagnosed aml defined according to the world health organization (who)-classification (excluding acute promyelocytic leukemia [apl])

Datentyp

boolean

Alias
UMLS CUI [1]
C0023467
ages 18-60 years
Beschreibung

ages 18-60 years

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
written informed consent of each patient at study entry.
Beschreibung

written informed consent of each patient at study entry.

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
molecular and cytogenetical diagnostics on initial bone marrow and peripheral blood specimen at the central reference laboratories
Beschreibung

molecular and cytogenetical diagnostics

Datentyp

boolean

Alias
UMLS CUI [1]
C2121080
UMLS CUI [2]
C0010802
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
bleeding independent of the aml
Beschreibung

bleeding independent of the aml

Datentyp

boolean

Alias
UMLS CUI [1]
C0019080
UMLS CUI [2]
C0023467
acute promyelocytic leukemia
Beschreibung

acute promyelocytic leukemia

Datentyp

boolean

Alias
UMLS CUI [1]
C0023487
uncontrollable infection
Beschreibung

uncontrollable infection

Datentyp

boolean

Alias
UMLS CUI [1]
C0009488
participation in a concurrent clinical study
Beschreibung

participation in a concurrent clinical study

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
insufficiency of the kidneys (creatinine > 1.5x upper normal serum level), of the liver (bilirubin, ast or ap > 2x upper normal serum level), severe obstructive or restrictive ventilation disorder, heart failure new york heart association (nyha) iii/iv
Beschreibung

insufficiency of the kidneys (creatinine > 1.5x upper normal serum level), of the liver (bilirubin, ast or ap > 2x upper normal serum level), severe obstructive or restrictive ventilation disorder, heart failure new york heart association (nyha) iii/iv

Datentyp

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0201836
UMLS CUI [4]
C0201850
UMLS CUI [5]
C0035204
UMLS CUI [6]
C1275491
severe neurological or psychiatric disorder interfering with ability to give an informed consent.
Beschreibung

severe neurological or psychiatric disorder interfering with ability to give an informed consent.

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
no consent for registration, storage and processing of the individual disease-characteristics and course.
Beschreibung

no consent for registration, storage and processing of the individual disease-characteristics and course.

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
performance status who > 2
Beschreibung

performance status who

Datentyp

boolean

Alias
UMLS CUI [1]
C1298650
pregnancy
Beschreibung

pregnancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961

Ähnliche Modelle

Eligibility Acute Myeloid Leukemia NCT00151242

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
AML
Item
newly diagnosed aml defined according to the world health organization (who)-classification (excluding acute promyelocytic leukemia [apl])
boolean
C0023467 (UMLS CUI [1])
Age
Item
ages 18-60 years
boolean
C0001779 (UMLS CUI [1])
written informed consent
Item
written informed consent of each patient at study entry.
boolean
C0021430 (UMLS CUI [1])
molecular and cytogenetical diagnostics
Item
molecular and cytogenetical diagnostics on initial bone marrow and peripheral blood specimen at the central reference laboratories
boolean
C2121080 (UMLS CUI [1])
C0010802 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
bleeding
Item
bleeding independent of the aml
boolean
C0019080 (UMLS CUI [1])
C0023467 (UMLS CUI [2])
APL
Item
acute promyelocytic leukemia
boolean
C0023487 (UMLS CUI [1])
uncontrollable infection
Item
uncontrollable infection
boolean
C0009488 (UMLS CUI [1])
participation in a concurrent clinical study
Item
participation in a concurrent clinical study
boolean
C2348568 (UMLS CUI [1])
organ function
Item
insufficiency of the kidneys (creatinine > 1.5x upper normal serum level), of the liver (bilirubin, ast or ap > 2x upper normal serum level), severe obstructive or restrictive ventilation disorder, heart failure new york heart association (nyha) iii/iv
boolean
C0201976 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C0201850 (UMLS CUI [4])
C0035204 (UMLS CUI [5])
C1275491 (UMLS CUI [6])
severe neurological or psychiatric disorder interfering with ability to give an informed consent.
Item
severe neurological or psychiatric disorder interfering with ability to give an informed consent.
boolean
C0021430 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
no consent
Item
no consent for registration, storage and processing of the individual disease-characteristics and course.
boolean
C0021430 (UMLS CUI [1])
performance status who
Item
performance status who > 2
boolean
C1298650 (UMLS CUI [1])
pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video